Raymond James & Associates’s Corteva CTVA Stock Holding History
Bought
Maintained
Sold
Other funds holding CTVA
N
Raymond James & Associates's CTVA Position: Q3 2024 in Review
Raymond James & Associates increased its Corteva (CTVA) stake by 23% in Q3 2024, buying an estimated $5.17M and bringing the position to 505,375 shares worth $29.7M. The position accounts for 0.02% of the portfolio, ranked #627.
Raymond James & Associates first reported a position in CTVA in Q2 2019 and has held it in 22 quarters since. The position peaked at $36.3M in Q1 2022. 1,228 funds tracked by Wall St. Rank hold CTVA as of Q3 2024.
- Raymond James & Associates held 505,375 shares of Corteva worth $29.7M as of Q3 2024.
- Raymond James & Associates bought 94,689 Corteva shares in Q3 2024, an estimated $5.17M.
- Corteva made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #627 holding.
- Raymond James & Associates first reported a position in Corteva in Q2 2019 and has held it in 22 quarters since.
- Raymond James & Associates's Corteva position peaked at $36.3M in Q1 2022.
- 1,228 funds tracked by Wall St. Rank held Corteva as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.